http://120.24.161.253:5617/index.php?action=history&feed=atom&title=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E-%E9%A2%84%E5%90%8E%E7%8A%B6%E5%86%B5-%E9%A2%84%E5%90%8E%E4%B8%8D%E4%BD%B3
重症肺炎-预后状况-预后不佳 - 版本历史
2026-05-01T07:17:21Z
本wiki的该页面的版本历史
MediaWiki 1.30.0
http://120.24.161.253:5617/index.php?title=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E-%E9%A2%84%E5%90%8E%E7%8A%B6%E5%86%B5-%E9%A2%84%E5%90%8E%E4%B8%8D%E4%BD%B3&diff=1756110&oldid=prev
Admin：修改1
2024-07-06T14:00:00Z
<p>修改1</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 14:00的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E-%E9%A2%84%E5%90%8E%E7%8A%B6%E5%86%B5-%E9%A2%84%E5%90%8E%E4%B8%8D%E4%BD%B3&diff=1756111&oldid=prev
KGadmin：导入1个版本
2024-07-06T13:02:04Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="2" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="2" style="background-color: white; color:black; text-align: center;">2024年7月6日 (六) 13:02的版本</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l7" >第7行：</td>
<td colspan="2" class="diff-lineno">第7行：</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>==来源==</div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===小儿重症腺病毒肺炎合并其他病原体感染特征及高危因素探讨（中华医学会文献）===</div></td><td class='diff-marker'> </td><td style="background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;"><div>===小儿重症腺病毒肺炎合并其他病原体感染特征及高危因素探讨（中华医学会文献）===</div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>56例[[重症肺炎]]患儿分为预后良好组29例与[[预后不佳]]组27例,[[预后不佳]]组先天性气道发育不良、血红蛋白<del class="diffchange diffchange-inline"><</del>90 g/L、白蛋白<del class="diffchange diffchange-inline"><</del>30 g/L、C反应蛋白<del class="diffchange diffchange-inline">></del>30 mg/L、降钙素原<del class="diffchange diffchange-inline">></del>10μg/L、急性肺损伤、循环系统并发症、≥3种并发症发生率明显高于预后良好组差异有</div></td><td class='diff-marker'>+</td><td style="color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>56例[[重症肺炎]]患儿分为预后良好组29例与[[预后不佳]]组27例,[[预后不佳]]组先天性气道发育不良、血红蛋白<ins class="diffchange diffchange-inline">&amp;lt;</ins>90 g/L、白蛋白<ins class="diffchange diffchange-inline">&amp;lt;</ins>30 g/L、C反应蛋白<ins class="diffchange diffchange-inline">&amp;gt;</ins>30 mg/L、降钙素原<ins class="diffchange diffchange-inline">&amp;gt;</ins>10μg/L、急性肺损伤、循环系统并发症、≥3种并发症发生率明显高于预后良好组差异有</div></td></tr>
</table>
KGadmin
http://120.24.161.253:5617/index.php?title=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E-%E9%A2%84%E5%90%8E%E7%8A%B6%E5%86%B5-%E9%A2%84%E5%90%8E%E4%B8%8D%E4%BD%B3&diff=794114&oldid=prev
Admin：导入1个版本
2021-11-23T04:04:43Z
<p>导入1个版本</p>
<table class="diff diff-contentalign-left" data-mw="interface">
<tr style="vertical-align: top;" lang="zh-CN">
<td colspan="1" style="background-color: white; color:black; text-align: center;">←上一版本</td>
<td colspan="1" style="background-color: white; color:black; text-align: center;">2021年11月23日 (二) 04:04的版本</td>
</tr><tr><td colspan="2" style="text-align: center;" lang="zh-CN"><div class="mw-diff-empty">（没有差异）</div>
</td></tr></table>
Admin
http://120.24.161.253:5617/index.php?title=%E9%87%8D%E7%97%87%E8%82%BA%E7%82%8E-%E9%A2%84%E5%90%8E%E7%8A%B6%E5%86%B5-%E9%A2%84%E5%90%8E%E4%B8%8D%E4%BD%B3&diff=794109&oldid=prev
Admin：修改1
2021-10-19T13:56:59Z
<p>修改1</p>
<p><b>新页面</b></p><div>主实体：[[重症肺炎]]，关系：[[预后状况]] ，尾实体：[[预后不佳]]<br />
<br />
实体ID:''10176538''<br />
==关系介绍==<br />
待补充<br />
<br />
==来源==<br />
===小儿重症腺病毒肺炎合并其他病原体感染特征及高危因素探讨（中华医学会文献）===<br />
56例[[重症肺炎]]患儿分为预后良好组29例与[[预后不佳]]组27例,[[预后不佳]]组先天性气道发育不良、血红蛋白<90 g/L、白蛋白<30 g/L、C反应蛋白>30 mg/L、降钙素原>10μg/L、急性肺损伤、循环系统并发症、≥3种并发症发生率明显高于预后良好组差异有</div>
Admin